Pro Feature
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moMOXIFLOXACIN HYDROCHLORIDE (moxifloxacin hydrochloride) by Sunshine Biopharma is [see microbiology ( )]. Approved for haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus and 21 more indications. First approved in 2018.
Drug data last refreshed 22h ago
[see Microbiology ( )].
Worked on MOXIFLOXACIN HYDROCHLORIDE at Sunshine Biopharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic Surgery
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo